Clinical Trials · NCT01460069
The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Annesofie Faurschou
- Enrollment
- 20
- Start date
- Oct 2011
- Locations
- 1 site, Denmark
- Primary endpoint
- PASI (psoriasis area and severity index)